157 related articles for article (PubMed ID: 25744546)
1. Plasma osteoprotegerin concentrations in type 1 diabetic patients with albuminuria.
Elsamahy MH; Elhenawy YI; Nawar MM
J Diabetes Complications; 2015; 29(4):563-7. PubMed ID: 25744546
[TBL] [Abstract][Full Text] [Related]
2. Increased plasma osteoprotegerin concentrations in Type 1 diabetes with albuminuria.
Wang ST; Xu JM; Wang M; Chen FL; Ding G
Clin Nephrol; 2013 Mar; 79(3):192-8. PubMed ID: 23073066
[TBL] [Abstract][Full Text] [Related]
3. Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy.
Chang YH; Lin KD; He SR; Hsieh MC; Hsiao JY; Shin SJ
Metabolism; 2011 Aug; 60(8):1064-9. PubMed ID: 21251686
[TBL] [Abstract][Full Text] [Related]
4. Association between plasma osteoprotegerin concentrations and urinary albumin excretion in Type 2 diabetes.
Xiang GD; Pu JH; Zhao LS; Sun HL; Hou J; Yue L
Diabet Med; 2009 Apr; 26(4):397-403. PubMed ID: 19388970
[TBL] [Abstract][Full Text] [Related]
5. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
[TBL] [Abstract][Full Text] [Related]
6. Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications.
Knudsen ST; Foss CH; Poulsen PL; Andersen NH; Mogensen CE; Rasmussen LM
Eur J Endocrinol; 2003 Jul; 149(1):39-42. PubMed ID: 12824864
[TBL] [Abstract][Full Text] [Related]
7. The plasma osteoprotegerin level and osteoprotegerin expression in renal biopsy tissue are increased in type 2 diabetes with nephropathy.
Wang ST; Zhang CY; Zhang CM; Rong W
Exp Clin Endocrinol Diabetes; 2015 Feb; 123(2):106-11. PubMed ID: 25502845
[TBL] [Abstract][Full Text] [Related]
8. YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.
Rathcke CN; Persson F; Tarnow L; Rossing P; Vestergaard H
Diabetes Care; 2009 Feb; 32(2):323-8. PubMed ID: 18957531
[TBL] [Abstract][Full Text] [Related]
9. Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes?
Grauslund J; Rasmussen LM; Green A; Sjølie AK
Scand J Clin Lab Invest; 2010 Apr; 70(3):188-93. PubMed ID: 20205614
[TBL] [Abstract][Full Text] [Related]
10. Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes.
Theilade S; Lyngbaek S; Hansen TW; Eugen-Olsen J; Fenger M; Rossing P; Jeppesen JL
J Intern Med; 2015 Mar; 277(3):362-371. PubMed ID: 24830873
[TBL] [Abstract][Full Text] [Related]
11. Association between osteoprotegerin, fetuin-A, carotid intima media thickness, and urinary albumin excretion in Type 2 diabetes.
Koluman BU; Mutluay R; Derici UB; Arinsoy T; Senlik Z; Bahar B; Sancak B; Oktan SO; Sindel S
Clin Nephrol; 2013 Jul; 80(1):9-16. PubMed ID: 23458176
[TBL] [Abstract][Full Text] [Related]
12. Plasma osteoprotegerin concentrations in type 2 diabetic patients and its association with neuropathy.
Terekeci HM; Senol MG; Top C; Sahan B; Celik S; Sayan O; Kucukardali Y; Ipcioglu O; Cagiltay E; Oktenli C; Ozata M
Exp Clin Endocrinol Diabetes; 2009 Mar; 117(3):119-23. PubMed ID: 19053023
[TBL] [Abstract][Full Text] [Related]
13. Serum and urinary type IV collagen concentrations in the assessment of diabetic microangiopathy.
Banu N; Hara H; Egusa G; Yamakido M
Hiroshima J Med Sci; 1994 Dec; 43(4):123-33. PubMed ID: 7883578
[TBL] [Abstract][Full Text] [Related]
14. Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients.
Wirta OR; Pasternack AI; Mustonen JT; Koivula TA; Harmoinen A
Nephrol Dial Transplant; 1996 Mar; 11(3):449-56. PubMed ID: 8671814
[TBL] [Abstract][Full Text] [Related]
15. Plasma homocysteine, oxidative stress and endothelial function in patients with Type 1 diabetes mellitus and microalbuminuria.
Wotherspoon F; Laight DW; Browne DL; Turner C; Meeking DR; Allard SE; Munday LJ; Shaw KM; Cummings MH
Diabet Med; 2006 Dec; 23(12):1350-6. PubMed ID: 17116187
[TBL] [Abstract][Full Text] [Related]
16. Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients.
Xiang GD; Sun HL; Zhao LS
Diabetes Res Clin Pract; 2007 May; 76(2):199-206. PubMed ID: 17023086
[TBL] [Abstract][Full Text] [Related]
17. Serum Angptl2 levels are independently associated with albuminuria in type 2 diabetes.
Li Q; Gong W; Yang Z; Lu B; Yang Y; Zhao W; Hu R
Diabetes Res Clin Pract; 2013 Jun; 100(3):385-90. PubMed ID: 23602322
[TBL] [Abstract][Full Text] [Related]
18. Plasma osteoprotegerin concentrations in peripheral sensory neuropathy in Type 1 and Type 2 diabetic patients.
Nybo M; Poulsen MK; Grauslund J; Henriksen JE; Rasmussen LM
Diabet Med; 2010 Mar; 27(3):289-94. PubMed ID: 20536491
[TBL] [Abstract][Full Text] [Related]
19. Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular morbidity in type 1 diabetic patients.
Rasmussen LM; Tarnow L; Hansen TK; Parving HH; Flyvbjerg A
Eur J Endocrinol; 2006 Jan; 154(1):75-81. PubMed ID: 16381994
[TBL] [Abstract][Full Text] [Related]
20. Urinary excretion of apolipoprotein(a) fragments in type 1 diabetes mellitus patients.
Clodi M; Oberbauer R; Bodlaj G; Hofmann J; Maurer G; Kostner K
Metabolism; 1999 Mar; 48(3):369-72. PubMed ID: 10094115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
